Quote
Joe
No doubt there is lots of new info re Flec?
I assume you are referring his comments on the CAST trial. Here is a
wiki. The study paper is
here.
Note
here. "Do not use in patients with recent or prior MI." From CAST, "BACKGROUND AND METHODS.
In the Cardiac Arrhythmia Suppression Trial, d
esigned to test the hypothesis that suppression of ventricular ectopy after a myocardial infarction reduces the incidence of sudden death, patients in whom ventricular ectopy could be suppressed with encainide, flecainide, or moricizine were randomly assigned to receive either active drug or placebo. The use of encainide and flecainide was discontinued because of excess mortality. We examined the mortality and morbidity after randomization to encainide or flecainide or their respective placebo."
I had this discussion around 2010 with my late mother's GP who is a friend. I believe it is CAST where the restriction on using flec with MI or heart failure patients comes from. Your doc should have reviewed your situation regarding MI/heart failure prior to prescribing flec, I know my EP did in 2004.
Edited 1 time(s). Last edit at 12/21/2022 08:04PM by GeorgeN.